There is 7500 retts patients on the register but the patient population is likely closer to 9000-10,000 patients.
At $375,000 per year treatment, if my maths is correct (which it is), only 2,666 patients need to be treated for a full CY to hit $1,000,000,000 in sales.
Anyone think only 1 in 5 parents who’s kids have retts will try and get their child on the treatment? The answer is No.
$2,000,000,000 in sales is likely let alone $1,000,000,000. Even after factoring in a 20-25% discontinuation rate.
USD.
Share Price, page-7947
-
- There are more pages in this discussion • 2,828 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |